CA2812132C - Anticorps naturels igm et ses inhibiteurs - Google Patents

Anticorps naturels igm et ses inhibiteurs Download PDF

Info

Publication number
CA2812132C
CA2812132C CA2812132A CA2812132A CA2812132C CA 2812132 C CA2812132 C CA 2812132C CA 2812132 A CA2812132 A CA 2812132A CA 2812132 A CA2812132 A CA 2812132A CA 2812132 C CA2812132 C CA 2812132C
Authority
CA
Canada
Prior art keywords
glu
leu
lys
ala
gin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2812132A
Other languages
English (en)
Other versions
CA2812132A1 (fr
Inventor
Michael C. Carroll
Francis D. Moore, Jr.
Herbert B. Hechtman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Boston Childrens Hospital
Harvard University
Original Assignee
Brigham and Womens Hospital Inc
Boston Childrens Hospital
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc, Boston Childrens Hospital, Harvard University filed Critical Brigham and Womens Hospital Inc
Priority claimed from CA002560066A external-priority patent/CA2560066A1/fr
Publication of CA2812132A1 publication Critical patent/CA2812132A1/fr
Application granted granted Critical
Publication of CA2812132C publication Critical patent/CA2812132C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
CA2812132A 2004-03-01 2005-03-01 Anticorps naturels igm et ses inhibiteurs Expired - Fee Related CA2812132C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US54912304P 2004-03-01 2004-03-01
US60/549,123 2004-03-01
US58864804P 2004-07-16 2004-07-16
US60/588,648 2004-07-16
CA002560066A CA2560066A1 (fr) 2004-03-01 2005-03-01 Anticorps naturels igm et leurs inhibiteurs

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002560066A Division CA2560066A1 (fr) 2004-03-01 2005-03-01 Anticorps naturels igm et leurs inhibiteurs

Publications (2)

Publication Number Publication Date
CA2812132A1 CA2812132A1 (fr) 2005-09-15
CA2812132C true CA2812132C (fr) 2016-08-09

Family

ID=38126323

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2812132A Expired - Fee Related CA2812132C (fr) 2004-03-01 2005-03-01 Anticorps naturels igm et ses inhibiteurs

Country Status (3)

Country Link
CN (1) CN1977043B (fr)
CA (1) CA2812132C (fr)
ES (1) ES2360964T3 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2801184A1 (fr) * 2010-06-03 2011-12-08 Abraxis Bioscience, Llc Anticorps anti-sparc du sang peripherique et leurs utilisations

Also Published As

Publication number Publication date
CN1977043B (zh) 2012-07-04
CN1977043A (zh) 2007-06-06
CA2812132A1 (fr) 2005-09-15
ES2360964T3 (es) 2011-06-10

Similar Documents

Publication Publication Date Title
US9914751B2 (en) Natural IGM antibodies and inhibitors thereof
US7875259B2 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
US20240024520A1 (en) Autonomous knob domain peptides
US20100136684A1 (en) Natural IgM Antibodies
CA2812132C (fr) Anticorps naturels igm et ses inhibiteurs
US20040131607A1 (en) Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury
AU2012200909B2 (en) Natural lgM antibodies and inhibitors thereof
EP1286682B1 (fr) Procedes et compositions pour inhiber les lesions au retour de la perfusion induites par l'immunoglobuline
HK1154904B (en) Natural igm antibodies and inhibitors thereof
KR20220048028A (ko) 항-cd19 항체 및 그의 용도
AU2016202118A1 (en) Carrier immunoglobulins and uses thereof
WO2024153146A1 (fr) Nouveaux anticorps anti-encéphalite auto-immune du récepteur nmda et leur utilisation
HK1150533A (en) Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130404

MKLA Lapsed

Effective date: 20200302